GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Pre-Tax Income

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Pre-Tax Income : $0.24 Mil (TTM As of Dec. 2018)


View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Parnell Pharmaceuticals Holdings's pretax income for the six months ended in Dec. 2018 was $0.24 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2018 was $0.24 Mil. Parnell Pharmaceuticals Holdings's pretax margin was 1.27%.


Parnell Pharmaceuticals Holdings Pre-Tax Income Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Pre-Tax Income Chart

Parnell Pharmaceuticals Holdings Annual Data
Trend Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Pre-Tax Income
Get a 7-Day Free Trial -13.44 -9.95 -15.93 -17.67 0.24

Parnell Pharmaceuticals Holdings Semi-Annual Data
Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Pre-Tax Income Get a 7-Day Free Trial -13.44 -9.95 -15.93 -17.67 0.24

Competitive Comparison of Parnell Pharmaceuticals Holdings's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parnell Pharmaceuticals Holdings's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's Pre-Tax Income falls into.



Parnell Pharmaceuticals Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Parnell Pharmaceuticals Holdings's Pretax Income for the fiscal year that ended in Dec. 2018 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=2.451+2.801+-5.014+0.003+0.001
=0.24

Parnell Pharmaceuticals Holdings's Pretax Income for the quarter that ended in Dec. 2018 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=2.451+2.801+-5.014+0.003+0.001
=0.24

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2018 was $0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnell Pharmaceuticals Holdings  (OTCPK:PARNF) Pre-Tax Income Explanation

Parnell Pharmaceuticals Holdings's Pretax Margin for the quarter that ended in Dec. 2018 is calculated as

Pretax Margin=Pretax Income/Revenue
=0.242/19.031
=1.27%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnell Pharmaceuticals Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Traded in Other Exchanges
N/A
Address
476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015
Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.